Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
批准号:
10671308
负责人:
ARAKI Norie
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
2型神经纤维瘤病(NF2)是一种常染色体显性遗传疾病,与包括双侧前庭神经鞘瘤和脑膜瘤在内的良性颅内肿瘤的发展密切相关。NF2基因最近被克隆,其编码的蛋白(称为merlin/schwannomin)被发现与细胞骨架相关蛋白moesin-ezrin-radixin (MER)家族惊人地相似。为了阐明NF2蛋白(merlin)的生物学功能,我们分析了merlin的突变模式、细胞定位以及通过merlin传递的细胞信号。1)采用蛋白截断法分析NF2患者的NF2基因突变。大多数NF2突变是无意义的,帧移位或外显子缺失突变。超过70%的突变集中在编码merlin的n端一半的区域。此外,在一些神经鞘瘤和脑膜瘤中发现了普遍存在的蛋白酶calpain对n -末端的蛋白水解裂解。这些结果表明,n -末端区域对肿瘤抑制功能至关重要。2)建立了突变体和野生NF2的细胞表达系统,并利用共聚焦激光扫描显微镜(CLSM)分析了它们的细胞定位。野生墨林蛋白表现出细胞质和膜下定位,这是由其核输出信号(NES)依赖的转运机制指导的。n端突变导致merlin的核积累。3)从牛脑提取物中纯化了merlin的细胞结合蛋白,通过对其内部氨基酸序列的分析,鉴定其为聚adp -核糖聚合酶、DNA-PK亚基ku -抗原85和70。merlin的n端(19-339)区域对它们的相互作用至关重要。免疫沉淀、western blotting和CLMS研究证实了它们的细胞共定位。NF2突变破坏梅林蛋白相关复合物的形成及其细胞信号传递。这种梅林细胞功能的丧失可能与颅内肿瘤的产生有关。少
英文摘要
The neurofibromatosis type 2 (NF2) is an autosomal dominantly inherited disorder, and strongly associated with development of benign intracranial tumors including bilateral vestibular schwannomas and meningiomas. NF2 gene was recently cloned, and the protein it encodes (termed as merlin/schwannomin) was found to be striking similarity to the moesin-ezrin-radixin (MER) family of cytoskeleton-associated proteins. To elucidate the biological function of NF2 protein (merlin), we analyzed the mutation pattern of merlin, its cellular localization, and the cellular signals via merlin. 1) NF2 gene mutations in NF2 patients were analyzed by protein truncation test. The majority of NF2 mutations are nonsense, frame shift, or exon-missing mutations. More than 70%of the mutations are clustered in the region encoding the N-terminal half of merlin. In addition, post-transrational proteolytic cleavage of N-terminal merlin by the ubiquitous protease calpain was found in some schwannomas and meningioma … More s. These results suggest that the N-terminal region of merlin is the most important for the tumor suppressive function, 2) Cellular expression systems of mutants or wild NF2 were established, and their cellular localization was analyzed by confocal lazer scanning Microscopy (CLSM). The wild merlin showed cytoplasmic and submembranous localization that was found to be directed by its nuclear export signal (NES) dependent transport mechanism. The N-terminal mutation resulted in nuclear accumulation of merlin. 3) Cellular binding proteins of merlin were purified from bovine brain extracts and identified as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70 by the analysis of their internal amino-acid sequences. The N-terminal(19-339) region of merlin is essential for their interaction. The immuno-precipitation, western blotting, and CLMS study confirmed their cellular co-localization. NF2 mutations impair the merlin-related complex formation and their cellular signal transport. This loss of cellular function of merlin may link to the intracranial tumor generation. Less
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kuwahara H, Araki N, Makino K, Masuko N, Honda S, Kaibuchi K, Fukunaga K Miyamoto E, Ogawa M, and Saya H: "A novel NE-dlg/SAP102-associated protein, p51-nedasin, related to the aminohydrolyse superfamily, interferes with the association between NE-dlg/SAP
Kuwahara H、Araki N、Makino K、Masuko N、Honda S、Kaibuchi K、Fukunaga K Miyamoto E、Okawa M 和 Saya H:“一种新型 NE-dlg/SAP102 相关蛋白 p51-nedasin,与氨基水解有关
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
masuko N, et al.: "Interaction of NE-dlg/SAP102, a neuron and endocrine tissue-specific membrane-associated guanylate kinase protein, with calmodulin and PSD-95/SAP90. A possible reguulatory role in molecular clustering at synaptic sites"J. Biol. Chem.. 2
Masuko N 等人:“NE-dlg/SAP102(一种神经元和内分泌组织特异性膜相关鸟苷酸激酶蛋白)与钙调蛋白和 PSD-95/SAP90 的相互作用。突触位点分子聚集中可能的调节作用”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N.,Saya,H.: "Cellular signal transduction via the neurofibromatosis type 2 tumor supressor gene product;Merlin."Seikagaku. 71(2). 43-49 (1999)
Araki,N.,Saya,H.:“通过神经纤维瘤病 2 型肿瘤抑制基因产物进行细胞信号转导;Merlin。”Seikagaku。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N.: "Cellular signal transduction via the neurofibromatosis type 2 tumor supressor gene product;Merlin." Seikagaku. 71(2). 43-49 (1999)
Araki,N.:“通过神经纤维瘤病 2 型肿瘤抑制基因产物进行细胞信号转导;Merlin。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shibayama R. et al.: "Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction"Diabetes.. 48(9). 1842-1849 (1999)
Shibayama R.等人:“针对N(ε)-(羧甲基)赖氨酸的自身抗体:美拉德反应的高级糖基化终产物”糖尿病.. 48(9)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Analysis of molecular network on maintenance and differentiation of glioma stem cells
-
批准号:25640068
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:ARAKI Norie
-
依托单位:
System development for microquantitative molecular analyses ofglioma stem cells
-
批准号:23659693
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:ARAKI Norie
-
依托单位:
Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
-
批准号:22390281
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
-
批准号:19390382
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:ARAKI Norie
-
依托单位:
Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
-
批准号:16390413
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2004
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products
-
批准号:14571319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
-
批准号:12671369
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:ARAKI Norie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LPS调控TFAM/NF2介导睾丸间质细胞铁死亡抑制雄激素合成的机制研究
-
批准号:QN25H040004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈显武
-
依托单位:
基质硬度微环境中 UBXN1 通过调控 NF2 泛素
化激活 YAP/TAZ 通路促进 HCC 生长转移
-
批准号:Y24H160144
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:窦常伟
-
依托单位:
抑癌基因NF2调控恶性胸膜间皮瘤核苷酸代谢的分子机制及靶向干预
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:许多
-
依托单位:
祛毒散结方通过改善肿瘤乏氧微环境抑制肿瘤相关巨噬细胞功能在NF2脑膜瘤治疗中的作用及机制研究
-
批准号:82304952
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李仕维
-
依托单位:
NF2/merlin与DCAF1 E3泛素连接酶互作介导肿瘤抑制的机理探索
-
批准号:82360610
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:崔岩
-
依托单位:
放射治疗NF2相关前庭神经鞘膜瘤诱发听觉神经元焦亡导致听力损伤的机制研究
-
批准号:82303686
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙瑶
-
依托单位:
MYC超级增强子激活促进NF2突变型脑膜瘤复发及进展的分子机制研究
-
批准号:82372752
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:宫晔
-
依托单位:
神经纤维瘤病2型NF2基因治疗安全性及有效性研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:薛璐
-
依托单位:
NF2及其磷酸化修饰通路在生理及病理性血管新生中的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王瑜
-
依托单位:
NF2基因改变通过SOX9介导的细胞周期调控参与肾癌演进的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:梁嘉宇
-
依托单位: